These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7082020)

  • 1. Applications of glucocorticosteroids. The effects of twice-daily vs once-every-other-day applications on mouse epidermal cell DNA synthesis.
    du Vivier A; Phillips H; Hehir M
    Arch Dermatol; 1982 May; 118(5):305-8. PubMed ID: 7082020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachyphylaxis to topically applied steroids.
    du Vivier A
    Arch Dermatol; 1976 Sep; 112(9):1245-8. PubMed ID: 999300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of retinoids on phorbol ester-stimulated epidermal DNA synthesis and hyperplasia in hairless mice.
    Gendimenico GJ; Nair X; Bouquin PL; Tramposch KM
    J Invest Dermatol; 1989 Sep; 93(3):363-7. PubMed ID: 2768837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute tolerance to effects of topical glucocorticosteroids.
    Vivier AD; Stoughton RB
    Br J Dermatol; 1976 Mar; 94 suppl 12():25-32. PubMed ID: 1268076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is steroid tachyphylaxis preventable?
    Clement M; Phillips H; du Vivier A
    Clin Exp Dermatol; 1985 Jan; 10(1):22-9. PubMed ID: 3987082
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
    Kao JS; Fluhr JW; Man MQ; Fowler AJ; Hachem JP; Crumrine D; Ahn SK; Brown BE; Elias PM; Feingold KR
    J Invest Dermatol; 2003 Mar; 120(3):456-64. PubMed ID: 12603860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of topical and systemic glucocorticosteroids on DNA synthesis in different tissues of the hairless mouse.
    Marshall RC; Burrows M; Brookes LG; du Vivier A
    Br J Dermatol; 1981 Nov; 105(5):517-20. PubMed ID: 7295568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal thinning: evaluation of commercial corticosteroids.
    Wrench R
    Arch Dermatol Res; 1980; 267(1):7-24. PubMed ID: 7387177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tachyphylaxis to the action of topically applied corticosteroids.
    du Vivier A; Stoughton RB
    Arch Dermatol; 1975 May; 111(5):581-3. PubMed ID: 1130802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An animal model for evaluating the local and systemic effects of topically applied corticosteroids on epidermal DNA synthesis.
    du Vivier A; Marshall RC; Brookes LG
    Br J Dermatol; 1978 Feb; 98(2):209-15. PubMed ID: 629875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses.
    Uliasz A; Zeichner J; Soung J; Wong V; Lebwohl M
    Cutis; 2008 Jun; 81(6):517-9. PubMed ID: 18666395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assay of topical corticosteroids. Efficacy of suppression of experimental Rhus dermatitis in humans.
    Kaidbey KH; Kligman AM
    Arch Dermatol; 1976 Jun; 112(6):808-13. PubMed ID: 133636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of amcinonide ointment 0.1 percent twice daily and fluocinonide ointment 0.05 percent three times daily in the treatment of psoriasis.
    Cornell RC
    Cutis; 1983 May; 31(5):566-9. PubMed ID: 6851655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.
    Lebwohl M; Ast E; Callen JP; Cullen SI; Hong SR; Kulp-Shorten CL; Lowe NJ; Phillips TJ; Rosen T; Wolf DI; Quell JM; Sefton J; Lue JC; Gibson JR; Chandraratna RA
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):705-11. PubMed ID: 9591815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hairless mouse as a model for study of local and systemic atrophogenic effects following topical application of corticosteroids.
    van den Hoven WE; van den Berg TP; Korstanje C
    Acta Derm Venereol; 1991; 71(1):29-31. PubMed ID: 1676210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucosylceramides stimulate mitogenesis in aged murine epidermis.
    Marchell NL; Uchida Y; Brown BE; Elias PM; Holleran WM
    J Invest Dermatol; 1998 Apr; 110(4):383-7. PubMed ID: 9540979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tachyphylaxis to histamine-induced wheal suppression by topical 0.05% clobetasol propionate in normal versus croton oil-induced dermatitic skin.
    Singh S; Gupta A; Pandey SS; Singh G
    Dermatology; 1996; 193(2):121-3. PubMed ID: 8884147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved method of assessing topical corticosteroid activity.
    Barnes H; Gaylarde PM; Brock AP; Sarkany I
    Br J Dermatol; 1975 Oct; 93(4):459-64. PubMed ID: 1201192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the biochemical activity in hairless mouse skin and other organs after systemic and topical methotrexate treatment.
    Yoshino K; Maibach HI
    J Dermatol; 1989 Dec; 16(6):475-9. PubMed ID: 2628454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.